Find Clinical Trial

Home » Find Clinical Trials » Comparative pharmacokinetic study of three prolonged release formulations and one immediate release formulation of S221237 after single oral administration in fed conditions. An open-label, randomized, four-period, four-sequence, one-way cross-over, single center, phase I study in Caucasian healthy male participants.

Comparative pharmacokinetic study of three prolonged release formulations and one immediate release formulation of S221237 after single oral administration in fed conditions. An open-label, randomized, four-period, four-sequence, one-way cross-over, single center, phase I study in Caucasian healthy male participants.

← Back

Study Phase	Phase 1

Therapeutic Area	Neuropsychiatric Diseases

Indication	No medical condition, Parkinson's disease

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S.)

Active substance/ Medical device	S221237

Active Substance Code	S221237

Protocol Code	S221237-176

Eu CT	2024-511270-72-00

Documents and links

Results are not yet available.

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.